Medtech industry veteran Sanjay Prabhakaran outlines the footprint and strategy of women’s health specialist Hologic in the dynamic Asia-Pacific region, how it leveraged its molecular diagnostics expertise to pivot towards COVID-19 diagnostics tests in 2020, and the leadership lessons he has learned from a 30-year corporate career with US multinationals.
Governments are now gearing up to the reality that without routine cancer screening of the population, the COVID problem may be addressed, but a bigger challenge with cancer is potentially looming in the years ahead
